Monique C.J. Hanse - Concepedia

Author

Monique C.J. Hanse

Also Known As

M C J Hanse, M Hanse, M. C. Hanse, M. C. J. Hanse, M. C. J. Hanse, M. Hanse, M.C.J. Hanse, Monique C Hanse, Monique C J Hanse, Monique C. J. Hanse

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Medisch Centrum Haaglanden Catharina Ziekenhuis Radboud University Nijmegen Elisabeth-TweeSteden Ziekenhuis Erasmus MC Cancer Institute

About

Monique C.J. Hanse is an author at Medisch Centrum Haaglanden specializing in medicine, neuro-oncology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.2K
2	Neurology	5	5	956
3	Social Sciences	1	1	50
4	Cell Biology	1	1	231
5	Neuroscience	1	1	50

Monique C.J. Hanse

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp, The Lancet Oncology Neuro-oncologyOncologySingle-agent BevacizumabMetronomic TherapyClinical Trials	2014	738
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma Youri Hoogstrate, Kaspar Draaisma, Santoesha A. Ghisai, Cancer Cell Neuro-oncologyGliomaTumor HeterogeneityBetter UnderstandingSingle Cell Sequencing	2023	231
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study Kaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, Journal of Clinical Oncology	2019	110
Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial Lale Erdem‐Eraslan, Martin J. van den Bent, Youri Hoogstrate, Cancer Research	2016	98
Recovery of Posterior Communicating Artery Aneurysm-Induced Oculomotor Palsy after Coiling Monique C.J. Hanse, M.C.F. Gerrits, Willem Jan van Rooij, American Journal of Neuroradiology	2008	75
A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of concept Karin Gehring, Martijn M. Stuiver, Eva Visser, Neuro-Oncology	2019	70
A randomized phase II study of bevacizumab versus bevacizumab plus lomustine versus lomustine single agent in recurrent glioblastoma: The Dutch BELOB study. Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp, Journal of Clinical Oncology High-grade GliomasRecurrent GlioblastomaGliomaNeuro-oncologyRadiation Medicine	2013	61
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial Linda Dirven, Martin J. van den Bent, Andrew Bottomley, European Journal of Cancer Neuro-oncologyOncologyHealth-related QualityCancer ManagementClinical Trials	2015	58
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial Renske Gahrmann, Martin J. van den Bent, Bronno van der Holt, Neuro-Oncology	2017	51
Antisaccades and remembered saccades in mild traumatic brain injury Luc Crevits, Monique C.J. Hanse, Philippe Tummers, Journal of Neurology Traumatic Brain InjuryNeuropsychologyBrain InjuryNeurologyNeuroscience	2000	50

Page 1